Skip to main content

Jun.-Prof. Dr. Laura Surace

Member

Institute of Clinical Chemistry and Clinical Pharmacology

BMZII, Venusberg-Campus 1, 53127 Bonn

lsurace@uni-bonn.de

+49 228 28751129

Website

Our research team works to understand the metabolic regulation and the role of tissue-resident lymphocytes in the maintenance of tissues homeostasis and during cancer development. Our aim is to uncover how dietary and host-derived metabolite availability influences immune cells in the tissues and the tumor microenvironment (TME). As the TME is metabolically challenging and immunosuppressive, our final goal is to support anti-tumorimmunity and improve treatment efficacy by targeting metabolic pathways.

Dr. Laura Surace

Recent publications

  • Common γ-chain cytokines induce an epigenomically plastic precursor-like KIT ILC2 state linked to immune disease susceptibility.

    The Journal of allergy and clinical immunology

    Authors: Simone E M Olsthoorn, Anne Onrust-Van Schoonhoven, Marjolein J W de Bruijn, Jochem Weekers, Menno van Nimwegen, Gregory van Beek, Willem de Koning, Lianne Trap, Esmee K van der Ploeg, Geert H van Weelden, Mathijs A Sanders, Laura Surace, James P Di Santo, Rudi W Hendriks, Ralph Stadhouders

    View this publication
  • Mef2d: a novel transcription factor in type 2 allergic lung inflammation.

    Signal transduction and targeted therapy

    Authors: Laura Surace, Christoph Wilhelm, Christian Bode

    View this publication
  • Host-pathogen interactions from a metabolic perspective: methods of investigation.

    Microbes and infection

    Authors: Caroline Demangel, Laura Surace

    View this publication